Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain | 22 | 2022 | 1543 | 2.180 |
Why?
|
| Magnetic Resonance Imaging | 18 | 2021 | 1032 | 2.030 |
Why?
|
| Cognitive Dysfunction | 13 | 2022 | 1005 | 1.600 |
Why?
|
| Gait | 6 | 2021 | 401 | 1.300 |
Why?
|
| Hippocampus | 6 | 2020 | 260 | 1.230 |
Why?
|
| Exercise | 6 | 2021 | 429 | 1.060 |
Why?
|
| Cognition | 10 | 2022 | 1270 | 1.050 |
Why?
|
| Alzheimer Disease | 15 | 2022 | 2026 | 0.940 |
Why?
|
| Aged, 80 and over | 28 | 2022 | 4508 | 0.940 |
Why?
|
| Aging | 8 | 2021 | 1458 | 0.900 |
Why?
|
| Postural Balance | 3 | 2021 | 116 | 0.870 |
Why?
|
| Postmortem Changes | 2 | 2016 | 30 | 0.840 |
Why?
|
| Independent Living | 5 | 2021 | 298 | 0.830 |
Why?
|
| Neuropathology | 3 | 2021 | 75 | 0.830 |
Why?
|
| Wearable Electronic Devices | 5 | 2021 | 43 | 0.700 |
Why?
|
| White Matter | 5 | 2018 | 123 | 0.690 |
Why?
|
| Male | 35 | 2022 | 13815 | 0.690 |
Why?
|
| Female | 35 | 2022 | 14161 | 0.670 |
Why?
|
| Humans | 47 | 2022 | 25165 | 0.630 |
Why?
|
| Autopsy | 9 | 2021 | 317 | 0.600 |
Why?
|
| Diffusion Tensor Imaging | 4 | 2021 | 57 | 0.600 |
Why?
|
| Aged | 25 | 2022 | 8448 | 0.590 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2018 | 48 | 0.570 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2018 | 103 | 0.540 |
Why?
|
| Range of Motion, Articular | 1 | 2019 | 655 | 0.510 |
Why?
|
| Motor Activity | 1 | 2018 | 314 | 0.490 |
Why?
|
| Thalamus | 3 | 2021 | 12 | 0.460 |
Why?
|
| Atrophy | 3 | 2021 | 88 | 0.460 |
Why?
|
| Knee Joint | 1 | 2019 | 662 | 0.440 |
Why?
|
| Parkinsonian Disorders | 3 | 2020 | 211 | 0.400 |
Why?
|
| Accelerometry | 4 | 2021 | 85 | 0.380 |
Why?
|
| Image Interpretation, Computer-Assisted | 6 | 2019 | 62 | 0.380 |
Why?
|
| Walking | 4 | 2022 | 248 | 0.370 |
Why?
|
| Neuroimaging | 3 | 2021 | 118 | 0.360 |
Why?
|
| Walking Speed | 2 | 2021 | 39 | 0.340 |
Why?
|
| Gray Matter | 3 | 2021 | 48 | 0.330 |
Why?
|
| Geriatric Assessment | 3 | 2021 | 203 | 0.330 |
Why?
|
| Longitudinal Studies | 7 | 2021 | 1301 | 0.330 |
Why?
|
| Formaldehyde | 1 | 2009 | 8 | 0.320 |
Why?
|
| RNA, Messenger | 2 | 2022 | 293 | 0.310 |
Why?
|
| Temporal Lobe | 2 | 2020 | 76 | 0.300 |
Why?
|
| Brain Mapping | 3 | 2017 | 141 | 0.290 |
Why?
|
| Cohort Studies | 8 | 2020 | 1772 | 0.290 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2020 | 174 | 0.290 |
Why?
|
| Parkinson Disease | 4 | 2021 | 653 | 0.280 |
Why?
|
| Dementia | 2 | 2022 | 532 | 0.260 |
Why?
|
| Organ Size | 3 | 2015 | 91 | 0.240 |
Why?
|
| Nerve Net | 2 | 2021 | 37 | 0.220 |
Why?
|
| Sclerosis | 3 | 2019 | 59 | 0.210 |
Why?
|
| Neuropsychological Tests | 3 | 2022 | 1141 | 0.200 |
Why?
|
| Transcriptome | 2 | 2022 | 85 | 0.200 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2020 | 84 | 0.200 |
Why?
|
| DNA Methylation | 3 | 2019 | 151 | 0.200 |
Why?
|
| Tremor | 2 | 2021 | 103 | 0.190 |
Why?
|
| Proteome | 1 | 2022 | 38 | 0.190 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2021 | 8 | 0.190 |
Why?
|
| Proteomics | 1 | 2022 | 82 | 0.180 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2021 | 8 | 0.180 |
Why?
|
| Motor Skills | 1 | 2021 | 46 | 0.180 |
Why?
|
| Cerebrovascular Disorders | 1 | 2022 | 123 | 0.180 |
Why?
|
| TDP-43 Proteinopathies | 2 | 2019 | 98 | 0.180 |
Why?
|
| Neuropeptides | 2 | 2019 | 25 | 0.180 |
Why?
|
| Frailty | 1 | 2021 | 31 | 0.180 |
Why?
|
| Hand Strength | 1 | 2021 | 57 | 0.180 |
Why?
|
| Gene Expression | 2 | 2019 | 186 | 0.170 |
Why?
|
| Sarcopenia | 1 | 2021 | 30 | 0.170 |
Why?
|
| Cognitive Aging | 1 | 2021 | 73 | 0.170 |
Why?
|
| Cognition Disorders | 3 | 2017 | 943 | 0.170 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 119 | 0.160 |
Why?
|
| Cerebral Hemorrhage | 1 | 2020 | 88 | 0.160 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 146 | 0.160 |
Why?
|
| Brain Ischemia | 1 | 2020 | 59 | 0.160 |
Why?
|
| Adenylate Kinase | 1 | 2019 | 5 | 0.160 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 6 | 0.160 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2019 | 15 | 0.160 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 12 | 0.160 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 22 | 0.160 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 79 | 0.160 |
Why?
|
| Disabled Persons | 1 | 2021 | 119 | 0.160 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2021 | 133 | 0.160 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2018 | 10 | 0.160 |
Why?
|
| Memory | 3 | 2017 | 286 | 0.160 |
Why?
|
| Electric Stimulation Therapy | 1 | 2018 | 40 | 0.150 |
Why?
|
| Bone Resorption | 1 | 2019 | 79 | 0.150 |
Why?
|
| Muscle Strength | 1 | 2019 | 124 | 0.150 |
Why?
|
| Nerve Fibers | 1 | 2018 | 11 | 0.150 |
Why?
|
| Disability Evaluation | 1 | 2019 | 252 | 0.140 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 24 | 0.140 |
Why?
|
| Circle of Willis | 1 | 2017 | 3 | 0.140 |
Why?
|
| Brain Infarction | 1 | 2017 | 72 | 0.140 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 32 | 0.140 |
Why?
|
| Femur | 1 | 2020 | 338 | 0.140 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2017 | 21 | 0.140 |
Why?
|
| Linear Models | 2 | 2016 | 238 | 0.140 |
Why?
|
| Epithalamus | 1 | 2016 | 1 | 0.140 |
Why?
|
| Afferent Pathways | 1 | 2016 | 3 | 0.140 |
Why?
|
| Plasmacytoma | 1 | 2016 | 7 | 0.130 |
Why?
|
| Sphenoid Sinus | 1 | 2016 | 13 | 0.130 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 84 | 0.130 |
Why?
|
| Neurons | 1 | 2019 | 322 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 138 | 0.130 |
Why?
|
| Membrane Proteins | 1 | 2017 | 148 | 0.130 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2016 | 63 | 0.130 |
Why?
|
| Neocortex | 1 | 2016 | 30 | 0.130 |
Why?
|
| Sleep Deprivation | 1 | 2016 | 44 | 0.120 |
Why?
|
| Algorithms | 2 | 2019 | 338 | 0.120 |
Why?
|
| Proportional Hazards Models | 3 | 2021 | 324 | 0.120 |
Why?
|
| Young Adult | 5 | 2021 | 1813 | 0.120 |
Why?
|
| Adult | 8 | 2021 | 7259 | 0.120 |
Why?
|
| Joint Instability | 1 | 2019 | 353 | 0.120 |
Why?
|
| Locomotion | 1 | 2014 | 23 | 0.110 |
Why?
|
| Shoulder Joint | 1 | 2019 | 577 | 0.100 |
Why?
|
| Femoracetabular Impingement | 1 | 2020 | 347 | 0.100 |
Why?
|
| Middle Aged | 6 | 2021 | 8303 | 0.100 |
Why?
|
| Memory, Episodic | 1 | 2011 | 105 | 0.090 |
Why?
|
| Models, Anatomic | 1 | 2010 | 36 | 0.090 |
Why?
|
| Mortality | 2 | 2021 | 84 | 0.080 |
Why?
|
| Fixatives | 1 | 2009 | 6 | 0.080 |
Why?
|
| Sex Factors | 2 | 2021 | 430 | 0.080 |
Why?
|
| Risk Factors | 3 | 2021 | 2179 | 0.080 |
Why?
|
| Chicago | 2 | 2021 | 916 | 0.070 |
Why?
|
| Lewy Bodies | 2 | 2019 | 179 | 0.070 |
Why?
|
| DNA-Binding Proteins | 2 | 2019 | 250 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2018 | 155 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 637 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 641 | 0.060 |
Why?
|
| Depression | 2 | 2017 | 428 | 0.050 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 15 | 0.050 |
Why?
|
| Mass Spectrometry | 1 | 2022 | 34 | 0.050 |
Why?
|
| Physical Therapy Modalities | 1 | 2022 | 67 | 0.050 |
Why?
|
| Executive Function | 1 | 2022 | 106 | 0.050 |
Why?
|
| Self-Assessment | 1 | 2021 | 29 | 0.040 |
Why?
|
| Frail Elderly | 1 | 2021 | 48 | 0.040 |
Why?
|
| Self Report | 1 | 2021 | 212 | 0.040 |
Why?
|
| Movement | 1 | 2020 | 107 | 0.040 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2019 | 3 | 0.040 |
Why?
|
| Nestin | 1 | 2019 | 3 | 0.040 |
Why?
|
| Fitness Trackers | 1 | 2019 | 13 | 0.040 |
Why?
|
| Mobility Limitation | 1 | 2020 | 91 | 0.040 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2019 | 8 | 0.040 |
Why?
|
| Neurogenesis | 1 | 2019 | 8 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 19 | 0.040 |
Why?
|
| SNARE Proteins | 1 | 2019 | 13 | 0.040 |
Why?
|
| Epilepsies, Partial | 1 | 2018 | 13 | 0.040 |
Why?
|
| Software | 1 | 2019 | 58 | 0.040 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2018 | 32 | 0.040 |
Why?
|
| Life Style | 1 | 2020 | 180 | 0.040 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2017 | 10 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2019 | 479 | 0.040 |
Why?
|
| alpha-Macroglobulins | 1 | 2017 | 11 | 0.040 |
Why?
|
| Substantia Nigra | 1 | 2019 | 116 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 41 | 0.040 |
Why?
|
| Age Factors | 1 | 2020 | 712 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 852 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 37 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 836 | 0.040 |
Why?
|
| Shoulder Injuries | 1 | 2019 | 130 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 634 | 0.040 |
Why?
|
| Incidence | 1 | 2020 | 704 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2018 | 251 | 0.040 |
Why?
|
| Netrin Receptors | 1 | 2017 | 5 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 42 | 0.030 |
Why?
|
| RNA | 1 | 2017 | 35 | 0.030 |
Why?
|
| Habenula | 1 | 2016 | 1 | 0.030 |
Why?
|
| Functional Laterality | 1 | 2017 | 58 | 0.030 |
Why?
|
| Prognosis | 1 | 2019 | 693 | 0.030 |
Why?
|
| Alleles | 1 | 2017 | 211 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 78 | 0.030 |
Why?
|
| Deep Brain Stimulation | 1 | 2016 | 32 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 133 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 571 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 266 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 267 | 0.030 |
Why?
|
| Genotype | 1 | 2017 | 338 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 1672 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 1618 | 0.030 |
Why?
|
| Actigraphy | 1 | 2016 | 92 | 0.030 |
Why?
|
| United States | 1 | 2021 | 1928 | 0.030 |
Why?
|
| Prefrontal Cortex | 1 | 2016 | 131 | 0.030 |
Why?
|
| Muscle Rigidity | 1 | 2014 | 20 | 0.030 |
Why?
|
| Hypokinesia | 1 | 2014 | 21 | 0.030 |
Why?
|
| Sleep | 1 | 2016 | 290 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2013 | 45 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 169 | 0.030 |
Why?
|
| Stroke | 1 | 2016 | 245 | 0.020 |
Why?
|
| Cadaver | 1 | 2013 | 342 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 450 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 2018 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 3185 | 0.020 |
Why?
|
| Radiography | 1 | 2009 | 566 | 0.020 |
Why?
|